isoxazoles has been researched along with Weight Reduction in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 15 (65.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doğan, EA; Erdoğan, Ç; Genç, BO; Genç, E | 1 |
| Chen, B; Media, J; Shaw, J; Valeriote, F | 1 |
| Apovian, CM; Aronne, LJ | 2 |
| Gadde, KM | 1 |
| Eskandari, D; Grote, L; Hedner, J; Karimi, M; Stenlöf, K; Zou, D | 1 |
| Giorgi, L; Lagae, L; Meshram, C; Patten, A | 1 |
| Fujioka, K | 1 |
| Horvath, R; Janszky, J; Komoly, S | 1 |
| Berges, W; Donner, P; Gugenberger, C; Naami, A | 1 |
| Barcs, G; Fabó, D; Halász, P; Jakus, R; Juhos, V; Kelemen, A; Neuwirth, M; Pálfy, B; Rásonyl, G; Szucs, A | 1 |
| Han, C; Joe, SH; Ko, YH; Lee, MS; Lim, J; Yang, J | 1 |
| Antel, J; Hebebrand, J | 1 |
| Kim, DW; Park, KS; Yoo, MW | 1 |
| Katz, MH | 1 |
| Allison, DB; Bray, GA; Gadde, KM; Kopping, MF; Wagner, HR; Yonish, GM | 1 |
| Franciscy, DM; Gadde, KM; Krishnan, KR; Wagner, HR | 1 |
| Vandooren, AK; Verschueren, P; Westhovens, R | 1 |
| D'Alessio, DA; Guerdjikova, AI; Hudson, JI; Keck, PE; Kotwal, R; Lake, KA; McElroy, SL; Nelson, EB; Welge, JA | 1 |
| Foust, MS; Gadde, KM; Wagner, HR; Yonish, GM | 1 |
| Beuers, U; Budenhofer, U; Kremer, AE; Rust, C | 1 |
| Coblyn, JS; Helfgott, S; Shadick, N | 1 |
| duToit, DF; Lyners, R; Mattysen, J; Muller, CJ; Muller, N; Page, BJ | 1 |
3 review(s) available for isoxazoles and Weight Reduction
| Article | Year |
|---|---|
Current and emerging medications for overweight or obesity in people with comorbidities.
Topics: Anti-Obesity Agents; Bupropion; Cinnamates; Comorbidity; Cyclohexanes; Diabetes Mellitus; Dyslipidemias; Epoxy Compounds; Humans; Hypertension; Isoxazoles; Obesity; Overweight; Prediabetic State; Sesquiterpenes; Weight Loss; Zonisamide | 2015 |
[ZONISAMIDE: FIRST CHOICE AMONG THE FIRST-LINE ANTIEPILEPTIC DRUGS IN FOCAL EPILEPSY].
Topics: Adolescent; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug Approval; Drug Prescriptions; Electroencephalography; Encephalitis; Epilepsies, Partial; Humans; Hungary; Isoxazoles; Levetiracetam; Magnetic Resonance Imaging; Medication Adherence; Obesity; Phenytoin; Piracetam; Risk Assessment; Risk Factors; Seizures; Stroke; Weight Loss; Young Adult; Zonisamide | 2015 |
Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide.
Topics: Animals; Anticonvulsants; Drug Therapy, Combination; Fructose; Humans; Isoxazoles; Risk Assessment; Risk Factors; Topiramate; Weight Loss; Zonisamide | 2012 |
6 trial(s) available for isoxazoles and Weight Reduction
| Article | Year |
|---|---|
Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study.
Topics: Aged; Anthropometry; Body Mass Index; Body Weight; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Continuous Positive Airway Pressure; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Patient Compliance; Placebos; Polysomnography; Sleep; Sleep Apnea, Obstructive; Weight Loss; Zonisamide | 2014 |
Effects of adjunctive zonisamide treatment on weight and body mass index in children with partial epilepsy.
Topics: Adolescent; Anticonvulsants; Body Mass Index; Child; Epilepsies, Partial; Female; Humans; Isoxazoles; Male; Weight Loss; Zonisamide | 2015 |
Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antioxidants; Body Mass Index; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Isoxazoles; Male; Middle Aged; Obesity; Retrospective Studies; Treatment Outcome; Weight Loss; Young Adult; Zonisamide | 2012 |
Zonisamide for weight loss in obese adults: a randomized controlled trial.
Topics: Adult; Anti-Obesity Agents; Anticonvulsants; Body Mass Index; Caloric Restriction; Combined Modality Therapy; Diet, Reducing; Double-Blind Method; Female; Humans; Isoxazoles; Life Style; Male; Obesity; Patient Education as Topic; Risk Reduction Behavior; Single-Blind Method; Treatment Outcome; Weight Loss; Zonisamide | 2003 |
Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
Topics: Adult; Anticonvulsants; Body Mass Index; Bulimia; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Obesity; Weight Loss; Zonisamide | 2006 |
Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study.
Topics: Adult; Analysis of Variance; Anti-Obesity Agents; Bupropion; Drug Therapy, Combination; Female; Humans; Isoxazoles; Obesity; Treatment Outcome; Waist-Hip Ratio; Weight Loss; Zonisamide | 2007 |
14 other study(ies) available for isoxazoles and Weight Reduction
| Article | Year |
|---|---|
Efficacy, tolerability, and retention rates of zonisamide in older adult patients with focal-onset epilepsy: Experiences from two tertiary epilepsy centers.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Drug Tolerance; Epilepsies, Partial; Female; Humans; Isoxazoles; Male; Middle Aged; Retrospective Studies; Seizures; Treatment Outcome; Weight Loss; Zonisamide | 2017 |
The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Cisplatin; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Isoxazoles; Maximum Tolerated Dose; Mice; Survival Rate; Time Factors; Tumor Necrosis Factor-alpha; Weight Loss | 2013 |
Zonisamide for weight reduction in obese adults.
Topics: Female; Humans; Isoxazoles; Male; Obesity; Weight Loss | 2013 |
Weight loss treatment in obese adults.
Topics: Female; Humans; Isoxazoles; Male; Obesity; Weight Loss | 2013 |
Weight loss treatment in obese adults--reply.
Topics: Female; Humans; Isoxazoles; Male; Obesity; Weight Loss | 2013 |
[Persistent diarrhea and loss of weight during therapy with leflunomide].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Colitis, Lymphocytic; Diabetes Mellitus, Type 1; Diarrhea; Female; Hashimoto Disease; Humans; Hypertension; Isoxazoles; Leflunomide; Middle Aged; Weight Loss | 2008 |
Our clinical experience with zonisamide in resistant generalized epilepsy syndromes.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Confusion; Disorders of Excessive Somnolence; Drug Resistance; Epilepsies, Myoclonic; Epilepsy, Absence; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Infant; Isoxazoles; Male; Middle Aged; Prospective Studies; Spasms, Infantile; Treatment Outcome; Weight Loss; Zonisamide | 2011 |
Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients.
Topics: Adult; Female; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Outpatients; Overweight; Psychotropic Drugs; Severity of Illness Index; Treatment Outcome; Weight Gain; Weight Loss; Zonisamide | 2011 |
Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Epilepsy; Female; Follow-Up Studies; Humans; Isoxazoles; Leptin; Linear Models; Middle Aged; Obesity; Prospective Studies; Weight Loss; Young Adult; Zonisamide | 2012 |
Zonisamide: no magic bullet.
Topics: Female; Humans; Isoxazoles; Male; Obesity; Weight Loss; Zonisamide | 2012 |
Debilitating diarrhoea and weight loss due to colitis in two RA patients treated with leflunomide.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biopsy; Colitis; Colon; Colonoscopy; Diagnosis, Differential; Diarrhea; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Isoxazoles; Leflunomide; Middle Aged; Weight Loss | 2005 |
[A 47-year-old dog breeder with chronic polyarthritis, weight loss and high fever].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Diagnosis, Differential; Disease Progression; Fever of Unknown Origin; Humans; Immunologic Deficiency Syndromes; Isoxazoles; Leflunomide; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Systemic Inflammatory Response Syndrome; Tropheryma; Weight Loss; Whipple Disease | 2008 |
Leflunomide-associated weight loss in rheumatoid arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Oxidative Phosphorylation; Weight Loss | 2001 |
Efficacy of malononitrilamide 715 as immunosuppressant, alone or in combination with cyclosporin, in allogeneic foetal rat pancreatic transplantation.
Topics: Alkynes; Animals; Cyclosporine; Drug Therapy, Combination; Fetal Tissue Transplantation; Immunosuppressive Agents; Isoxazoles; Nitriles; Pancreas Transplantation; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Subrenal Capsule Assay; T-Lymphocytes; Transplantation, Homologous; Weight Gain; Weight Loss | 2001 |